OTC Healthcare in Poland
Euromonitor International's OTC Healthcare in Poland market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 120 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Increased spending on OTC drugs
Rising disposable incomes have helped to fuel demand for OTC drugs in Poland. An increasing number of consumers are able to afford specialised medicines such as medicated skin care, eye care, and dietary supplements. In addition, favourable media reports and intensive product advertising have also helped to fuel sales.
New innovative products fuel demand
The fact that Polish consumers are extremely open to trying new products means that manufacturers invest heavily in research and development and regularly launch new innovative brands, especially within saturated categories like analgesics and cough, cold and allergy remedies, where competition is particularly fierce.
Multinationals dominate sales
Multinational companies dominate OTC healthcare sales in Poland. The financial resources available to such companies allow them to run nation-wide advertising campaigns for their brands as well as to introduce new innovative products on a regular basis. The main multinational players in the segment are GlaxoSmithKline, Bayer, and Reckitt Benckiser.
Non-pharmacy channel sales continue to increase
The non-pharmacy channel continues to rise in importance due to growing demand amongst consumers for convenience as a result of the increasingly hectic pace of modern life.
Further growth expected
OTC healthcare is expected to continue to develop over the forecast period as there is still significant scope for further expansion. The fastest growth is expected to be recorded within categories such as digestive remedies which offer products that help fight stress-related disorders. In addition, consumers will spend more on preventative medicine such as vitamins and dietary supplements and products which help to improve one’s appearance such as medicated skin care.
Table of contents
OTC HEALTHCARE IN POLAND : MARKET INSIGHT
EXECUTIVE SUMMARY
Increased spending on OTC drugs
New innovative products fuel demand
Multinationals dominate sales
Non-pharmacy channel sales continue to increase
Further growth expected
KEY TRENDS AND DEVELOPMENTS
Health and wellness trend increases in popularity
Self-medication increases in popularity
Lifestyle and environmental changes shape consumer behaviour
Innovations fuel growth
Increasing child-specific product sales
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventative Medicine
Generics
Re-classifications
Summary 1 OTC healthcare Switches 2005-2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - POLAND
AFLOFARM FARMACJA POLSKA SP ZOO - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Aflofarm Farmacja Polska Sp zoo: Key Facts
Summary 4 Aflofarm Farmacja Polska Sp zoo: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 5 Aflofarm Farmacja Polska Sp zoo: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 6 Aflofarm Farmacja Polska Sp zoo: Competitive Position 2008
JELFA SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Jelfa SA: Key Facts
Summary 8 Jelfa SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 9 Jelfa SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 10 Jelfa SA: Competitive Position 2008
POLPHARMA SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Polpharma SA: Key Facts
Summary 12 Polpharma SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 13 Polpharma SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 14 Polpharma SA: Competitive Position 2008
POLSKI LEK SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 15 Polski Lek SA: Key Facts
Summary 16 Polski Lek SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 17 Polski Lek SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 18 Polski Lek SA: Competitive Position 2008
PPF HASCO-LEK SA - OTC HEALTHCARE - POLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 19 PPF Hasco-Lek SA: Key Facts
Summary 20 PPF Hasco-Lek SA: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 21 PPF Hasco-Lek SA: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 22 PPF Hasco-Lek SA: Competitive Position 2008
ANALGESICS IN POLAND
HEADLINES
TRENDS
RE-CLASSIFICATIONS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 11 Sales of Analgesics by Subsector: Value 2003-2008
Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 13 Herbal vs Standard Topical Analgesics 2003-2008
Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 15 Analgesics Company Shares by Value 2004-2008
Table 16 Analgesics Brand Shares by Value 2005-2008
Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN POLAND
HEADLINES
TRENDS
RE-CLASSIFICATIONS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 21 Sales of Decongestants by Type: Value 2003-2008
Table 22 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 23 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 25 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 26 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 28 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN POLAND
HEADLINES
TRENDS
RE-CLASSIFICATIONS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 30 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 31 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 32 Herbal vs Standard Digestive Remedies 2003-2008
Table 33 Digestive Remedies Company Shares by Value 2004-2008
Table 34 Digestive Remedies Brand Shares by Value 2005-2008
Table 35 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 36 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN POLAND
HEADLINES
TRENDS
RE-CLASSIFICATIONS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 37 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 38 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 39 Herbal vs Standard Medicated Skin Care 2003-2008
Table 40 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 41 Medicated Skin Care Company Shares by Value 2004-2008
Table 42 Medicated Skin Care Brand Shares by Value 2005-2008
Table 43 Acne Treatments Brand Shares by Value 2005-2008
Table 44 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN POLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Dietary Supplements: Brand Ranking by Positioning 2008
SECTOR DATA
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 50 Folic Acid v Other B Vitamins 2004-2008
Table 51 Dietary Supplements by Positioning 2006-2008
Table 52 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 53 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 54 Vitamins Brand Shares by Value 2005-2008
Table 55 Dietary Supplements Brand Shares by Value 2005-2008
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN POLAND
HEADLINES
TRENDS
RE-CLASSIFICATIONS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 61 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 62 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 63 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN POLAND
SECTOR DATA
Table 66 Sales of Eye Care by Subsector: Value 2003-2008
Table 67 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 68 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 69 Eye Care Company Shares by Value 2004-2008
Table 70 Eye Care Brand Shares by Value 2005-2008
Table 71 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN POLAND
SECTOR DATA
Table 73 Sales of Ear Care: Value 2003-2008
Table 74 Sales of Ear Care: % Value Growth 2003-2008
Table 75 Ear Care Company Shares by Value 2004-2008
Table 76 Ear Care Brand Shares by Value 2005-2008
Table 77 Forecast Sales of Ear Care: Value 2008-2013
Table 78 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN POLAND
HEADLINES
SECTOR DATA
Table 79 Sales of Adult Mouth Care: Value 2003-2008
Table 80 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 81 Adult Mouth Care Company Shares by Value 2004-2008
Table 82 Adult Mouth Care Brand Shares by Value 2005-2008
Table 83 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 84 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN POLAND
SECTOR DATA
Table 85 Sales of Calming and Sleeping Products: Value 2003-2008
Table 86 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 87 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 88 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 89 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 90 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN POLAND
SECTOR DATA
Table 91 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 92 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 93 Wound Treatments Company Shares by Value 2004-2008
Table 94 Wound Treatments Brand Shares by Value 2005-2008
Table 95 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 96 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013
OTC OBESITY IN POLAND
SECTOR DATA
Table 97 Forecast Sales of OTC Obesity: Value 2009-2013
Table 98 Forecast Sales of OTC Obesity: % Value Growth 2009-2013
EMERGENCY CONTRACEPTION IN POLAND
TRENDS
OTC TRIPTANS IN POLAND
TRENDS